Category: Latest News
-
Roche lung cancer drug success adds to pressure on Bristol
By Ben Hirschler COPENHAGEN (Reuters) – Lung cancer patients on Roche’s immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb’s dominant position in the field. The trial involved second-line patients, who have already used chemotherapy, and it found the Roche drug worked even…
-
Roche lung cancer drug success adds to pressure on Bristol
By Ben Hirschler COPENHAGEN (Reuters) – Lung cancer patients on Roche’s immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb’s dominant position in the field. The trial involved second-line patients, who have already used chemotherapy, and it found the Roche drug worked even…
-
Medics dash to rural Haiti as cholera kills 13 in Matthew’s wake
By Makini Brice and Joseph Guyler Delva PORT SALUT, Haiti/PORT-AU-PRINCE (Reuters) – Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, officials said on Saturday, as government teams fanned out across the hard-hit southwestern tip of the country to repair treatment centers and reach the epicenter of one…
-
Medics dash to rural Haiti as cholera kills 13 in Matthew’s wake
By Makini Brice and Joseph Guyler Delva PORT SALUT, Haiti/PORT-AU-PRINCE (Reuters) – Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, officials said on Saturday, as government teams fanned out across the hard-hit southwestern tip of the country to repair treatment centers and reach the epicenter of one…
-
Far from Hurricane Matthew, a Haitian crisis flares in Tijuana
By Lizbeth Diaz TIJUANA, Mexico (Reuters) – The havoc wreaked by Hurricane Matthew has strengthened the resolve of thousands of Haitians stuck on the U.S.-Mexico border to make it to the United States even though new rules mean they will likely be deported to their shattered homeland. A surge in the number of Haitians seeking…
-
Far from Hurricane Matthew, a Haitian crisis flares in Tijuana
By Lizbeth Diaz TIJUANA, Mexico (Reuters) – The havoc wreaked by Hurricane Matthew has strengthened the resolve of thousands of Haitians stuck on the U.S.-Mexico border to make it to the United States even though new rules mean they will likely be deported to their shattered homeland. A surge in the number of Haitians seeking…
-
Medics head to southwest Haiti as Cholera kills 13 in Matthew’s wake
PORT-AU-PRINCE/LES CAYES, Haiti (Reuters) – Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, government officials told Reuters on Saturday, as health workers sought to reach the epicenter of one outbreak. Six people died of Cholera in a hospital in the southern town of Randel, which is inland…
-
Medics head to southwest Haiti as Cholera kills 13 in Matthew’s wake
PORT-AU-PRINCE/LES CAYES, Haiti (Reuters) – Cholera has killed at least 13 people in southwest Haiti in the wake of Hurricane Matthew, government officials told Reuters on Saturday, as health workers sought to reach the epicenter of one outbreak. Six people died of Cholera in a hospital in the southern town of Randel, which is inland…
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…